Coronavirus: Canadian company announces COVID-19 vaccine candidate
A Canadian company says it has made a breakthrough, claiming to have developed a COVID-19 vaccine candidate that could begin human testing as early as this summer.
Quebec City-based Medicago said it has produced a virus-like particle of the novel coronavirus, a first step towards producing a vaccine, which will now undergo pre-clinical testing for safety and efficacy.
Medicago said it could begin human trials as soon as July or August if approved by Health Canada and other agencies.
According to Global News, company CEO Bruce Clark told them that if the vaccine is successful it could be available to the wider public by November 2021. He said Medicago researchers were able to produce a candidate vaccine within just 20 days of obtaining the gene of the virus and if they are given the green light, they could produce as many as 10 million doses a month out of their plant in North Carolina. The company currently has the resources to create about two million doses a month out of its plant in Quebec.
Medical researchers around the world have been racing to develop a vaccine for COVID-19, which has sickened more than 127,000 people and killed roughly 5,000. As of Friday morning, there were 159 confirmed cases in Canada, including the prime minister’s wife Sophie Gregoire Trudeau.
Globally, there are roughly 20 coronavirus vaccine candidates being developed by research institutes and drugmakers, including America’s Johnson & Johnson and France’s Sanofi SA, according to Reuters.
The WHO has said that there’s currently no vaccine and no specific antiviral medicine to prevent or treat COVID-19, but that possible vaccines and some specific drug treatments are currently under investigation.
The World Health Organization ( WHO) projects that vaccine would not be widely available for another 12 to 18 months.
See more on coronavirus.
What do you think about the vaccine timeline? How is you community handling coronavirus outbreak?
Comments